
Sign up to save your podcasts
Or


This week, the White House announced a new initiative to tackle the growing use of fentanyl laced with xylazine — known to many as "tranq." This combination of drugs poses an alarming and significant threat to public health. The CDC reported last month that the percentage of fatal opioid overdoses in which xylazine was detected increased by 276% in just three years.
The Baker Institute’s fellow in drug policy, Katharine Neill Harris, discusses the rise in xylazine-laced fentanyl, as well as federal, state, and local policy approaches to curbing the nation’s overdose epidemic.
Discussants:
By Rice University’s Baker Institute for Public Policy5
2323 ratings
This week, the White House announced a new initiative to tackle the growing use of fentanyl laced with xylazine — known to many as "tranq." This combination of drugs poses an alarming and significant threat to public health. The CDC reported last month that the percentage of fatal opioid overdoses in which xylazine was detected increased by 276% in just three years.
The Baker Institute’s fellow in drug policy, Katharine Neill Harris, discusses the rise in xylazine-laced fentanyl, as well as federal, state, and local policy approaches to curbing the nation’s overdose epidemic.
Discussants:

7,869 Listeners

8,796 Listeners

4,405 Listeners

113,258 Listeners

57,057 Listeners

15 Listeners

2,028 Listeners

668 Listeners

6,106 Listeners

386 Listeners

10,273 Listeners